Connection
Karl Bayer to Alzheimer Disease
This is a "connection" page, showing publications Karl Bayer has written about Alzheimer Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.758 |
|
|
|
-
Larsen ME, Rumian NL, Quillinan N, Bayer KU. CaMKII mechanisms that promote pathological LTP impairments. Curr Opin Neurobiol. 2025 Jun; 92:102961.
Score: 0.629
-
Cook SG, Goodell DJ, Restrepo S, Arnold DB, Bayer KU. Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment. Cell Rep. 2019 04 16; 27(3):658-665.e4.
Score: 0.104
-
Opazo P, Viana da Silva S, Carta M, Breillat C, Coultrap SJ, Grillo-Bosch D, Sainlos M, Coussen F, Bayer KU, Mulle C, Choquet D. CaMKII Metaplasticity Drives A? Oligomer-Mediated Synaptotoxicity. Cell Rep. 2018 06 12; 23(11):3137-3145.
Score: 0.025